{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:00:28Z","timestamp":1773288028173,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Sexual Medicine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jsxm.2020.12.001","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T07:20:27Z","timestamp":1610954427000},"page":"353-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Androgen Deprivation Therapy in Pedophilic Disorder: Exploring the Physical, Psychological, and Sexual Effects From a Patient's Perspective"],"prefix":"10.1093","volume":"18","author":[{"given":"Lena","family":"Boons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Jeandarme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Vervaeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.jsxm.2020.12.001_bib1","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.jsxm.2020.12.001_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4065\/82.4.457","article-title":"A\u00a0Profile of Pedophilia: Definition, Characteristics of Offenders, Recidivism, Treatment Outcomes, and Forensic Issues","volume":"82","author":"Hall","year":"2007","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.jsxm.2020.12.001_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/15622971003671628","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias","volume":"11","author":"Thibaut","year":"2010","journal-title":"The World J Biol Psychiatry"},{"key":"10.1016\/j.jsxm.2020.12.001_bib4","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.3346\/jkms.2018.33.e231","article-title":"Therapeutic Effects of Leuprorelin (Leuprolide Acetate) in Sexual Offenders with Paraphilia","volume":"33","author":"Choi","year":"2018","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jsxm.2020.12.001_bib5","series-title":"Treating sex offenders: an evidence-based manual","author":"Stinson","year":"2012"},{"key":"10.1016\/j.jsxm.2020.12.001_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/13218719.2015.1054923","article-title":"The Good Lives Model: A New Paradigm for Forensic Mental Health","volume":"23","author":"Barnao","year":"2016","journal-title":"Psychiatry Psychol L"},{"key":"10.1016\/j.jsxm.2020.12.001_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10683160410001662780","article-title":"\u201cWhat works\u201d with mentally disordered offenders","volume":"10","author":"Blackburn","year":"2004","journal-title":"Psychol Crime L"},{"key":"10.1016\/j.jsxm.2020.12.001_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/15622975.2020.1744723","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders","volume":"21","author":"Thibaut","year":"2020","journal-title":"The World J Biol Psychiatry"},{"key":"10.1016\/j.jsxm.2020.12.001_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fnhum.2015.00344","article-title":"The Neurobiology and Psychology of Pedophilia: Recent Advances and Challenges","volume":"9","author":"Tenbergen","year":"2015","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.jsxm.2020.12.001_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jsxm.2017.11.013","article-title":"Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review","volume":"15","author":"Turner","year":"2018","journal-title":"The J Sex Med"},{"key":"10.1016\/j.jsxm.2020.12.001_bib11","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1111\/j.1743-6109.2011.02394.x","article-title":"The Role of Testosterone in Sexuality and Paraphilia\u2014A Neurobiological Approach. Part I: Testosterone and Sexuality","volume":"8","author":"Jordan","year":"2011","journal-title":"The J Sex Med"},{"key":"10.1016\/j.jsxm.2020.12.001_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1079063216637857","article-title":"Do Sex Offenders Have Higher Levels of Testosterone? Results From a Meta-Analysis","volume":"30","author":"Wong","year":"2018","journal-title":"Sex Abuse"},{"key":"10.1016\/j.jsxm.2020.12.001_bib13","first-page":"193","article-title":"The case for castration: a \u2018shot\u2019 towards rehabilitation of sexual offenders","volume":"37","author":"Chism","year":"2013","journal-title":"L\u00a0Psychol Rev"},{"key":"10.1016\/j.jsxm.2020.12.001_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1017\/mdh.2019.30","article-title":"\u2018We Won\u2019t Ban Castrating Pervs Despite What Europe Might Think!\u2019: Czech Medical Sexology and the Practice of Therapeutic Castration","volume":"63","author":"Li\u0161kov\u00e1","year":"2019","journal-title":"Med Hist"},{"key":"10.1016\/j.jsxm.2020.12.001_bib15","doi-asserted-by":"crossref","first-page":"c74","DOI":"10.1136\/bmj.c74","article-title":"Chemical castration for sex offenders","volume":"340","author":"Grubin","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jsxm.2020.12.001_bib16","doi-asserted-by":"crossref","unstructured":"Sauter J, Turner D, Briken P, et\u00a0al. Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses. Sex Abuse. https:\/\/doi.org\/10.1177\/1079063220910723. Accessed January 4, 2021.","DOI":"10.1177\/1079063220910723"},{"key":"10.1016\/j.jsxm.2020.12.001_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4088\/JCP.v64n0806","article-title":"Pharmacotherapy of Paraphilias With Long-Acting Agonists of Luteinizing Hormone\u2013Releasing Hormone: A Systematic Review","volume":"64","author":"Briken","year":"2003","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jsxm.2020.12.001_bib18","first-page":"1","article-title":"Pharmacological interventions for those who have sexually offended or are at risk of offending","volume":"2015","author":"Khan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jsxm.2020.12.001_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1192\/bjp.125.3.310","article-title":"The Control of Deviant Sexual Behaviour by Drugs: I. Behavioural changes following Oestrogens and Anti-Androgens","volume":"125","author":"Bancroft","year":"1974","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jsxm.2020.12.001_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF01542555","article-title":"Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias","volume":"22","author":"Bradford","year":"1993","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.jsxm.2020.12.001_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0022-4731(75)90310-6","article-title":"Antiandrogens in the treatment of sexual deviations of men","volume":"6","author":"Laschet","year":"1975","journal-title":"J\u00a0Steroid Biochem"},{"key":"10.1016\/j.jsxm.2020.12.001_bib22","first-page":"53","article-title":"Potential side effects of androgen deprivation treatment in sex offenders","volume":"37","author":"Giltay","year":"2009","journal-title":"J\u00a0Am Acad Psychiatry L"},{"key":"10.1016\/j.jsxm.2020.12.001_bib23","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer","volume":"24","author":"Keating","year":"2006","journal-title":"JCO"},{"key":"10.1016\/j.jsxm.2020.12.001_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.2047-2927.2013.00093.x","article-title":"Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines","volume":"1","author":"Cheung","year":"2013","journal-title":"Andrology"},{"key":"10.1016\/j.jsxm.2020.12.001_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0924-9338(02)00635-1","article-title":"Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics","volume":"17","author":"Czerny","year":"2002","journal-title":"Eur Psychiatr"},{"key":"10.1016\/j.jsxm.2020.12.001_bib26","doi-asserted-by":"crossref","first-page":"2002089","DOI":"10.1520\/JFS2002089","article-title":"Osteoporosis Associated with the Treatment of Paraphilias: A Clinical Review of Seven Case Reports","volume":"48","author":"Grasswick","year":"2003","journal-title":"J\u00a0Forensic Sci"},{"key":"10.1016\/j.jsxm.2020.12.001_bib27","first-page":"982","article-title":"The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning","volume":"23","author":"Lippi","year":"2017","journal-title":"S\u00a0Afr J Psych"},{"key":"10.1016\/j.jsxm.2020.12.001_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/070674370004500608","article-title":"Protocols for the Use of Cyproterone, Medroxyprogesterone, and Leuprolide in the Treatment of Paraphilia","volume":"45","author":"Reilly","year":"2000","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jsxm.2020.12.001_bib29","series-title":"Restrictions in use of cyproterone acetate due to meningioma risk; 2020","year":"2020"},{"key":"10.1016\/j.jsxm.2020.12.001_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/brief-treatment\/mhm022","article-title":"Evidential Basis for the Assessment and Treatment of Sex Offenders","volume":"8","author":"Bourget","year":"2008","journal-title":"Brief Treat Crisis Intervention"},{"key":"10.1016\/j.jsxm.2020.12.001_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jflm.2013.06.003","article-title":"Treatment outcomes of chemical castration on Korean sex offenders","volume":"20","author":"Koo","year":"2013","journal-title":"J\u00a0Forensic Leg Med"},{"key":"10.1016\/j.jsxm.2020.12.001_bib32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1743-6109.2012.02958.x","article-title":"Prescription of Testosterone-Lowering Medications for Sex Offender Treatment in German Forensic-Psychiatric Institutions","volume":"10","author":"Turner","year":"2013","journal-title":"The J Sex Med"},{"key":"10.1016\/j.jsxm.2020.12.001_bib33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/1079063218791176","article-title":"The Use of Leuprolide Acetate in the Management of High-Risk Sex Offenders","volume":"31","author":"Gallo","year":"2019","journal-title":"Sex Abuse"},{"key":"10.1016\/j.jsxm.2020.12.001_bib34","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamapsychiatry.2020.0440","article-title":"Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder: A Randomized Clinical Trial","volume":"77","author":"Landgren","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsxm.2020.12.001_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/13552600410001667733","article-title":"Sexual recidivism: A review of static, dynamic and actuarial predictors","volume":"11","author":"Craig","year":"2005","journal-title":"J\u00a0Sex Aggression"},{"key":"10.1016\/j.jsxm.2020.12.001_bib36","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/0269881117714048","article-title":"Gonadotrophin-releasing hormone agonist treatment for sexual offenders: A systematic review","volume":"31","author":"Lewis","year":"2017","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jsxm.2020.12.001_bib37","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1210\/jc.2011-1540","article-title":"Ethical and Medical Considerations of Androgen Deprivation Treatment of Sex Offenders","volume":"96","author":"Gooren","year":"2011","journal-title":"The J Clin Endocrinol Metab"},{"key":"10.1016\/j.jsxm.2020.12.001_bib38","series-title":"Opinion no. 39 of December 18th 2006 on hormonal treatment of sex offenders. Brussels: Federale overheidsdienst Volksgezondheid","year":"2006"},{"key":"10.1016\/j.jsxm.2020.12.001_bib39","first-page":"1","article-title":"Legal and ethical issues when using antiandrogenic pharmacotherapy with sex offenders","volume":"3","author":"Harrison","year":"2008","journal-title":"Sex Offender Treat"},{"key":"10.1016\/j.jsxm.2020.12.001_bib40","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.urolonc.2011.12.015","article-title":"Patients and partners lack knowledge of androgen deprivation therapy side effects","volume":"31","author":"Walker","year":"2013","journal-title":"Urol Oncol Semin Original Invest"},{"key":"10.1016\/j.jsxm.2020.12.001_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1361-9004(03)00042-6","article-title":"Development of an education package for men with prostate cancer on hormonal manipulation therapy","volume":"7","author":"Templeton","year":"2003","journal-title":"Clin Effectiveness Nurs"},{"key":"10.1016\/j.jsxm.2020.12.001_bib42","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/1049732303258016","article-title":"Advanced Prostate Cancer Patients\u2019 Ways of Coping with the Hormonal Therapy\u2019s Effect on Body, Sexuality, and Spousal Ties","volume":"13","author":"Navon","year":"2003","journal-title":"Qual Health Res"},{"key":"10.1016\/j.jsxm.2020.12.001_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7748\/nr2011.10.19.1.12.c8766","article-title":"Interviewing people about potentially sensitive topics","volume":"19","author":"Elmir","year":"2011","journal-title":"Nurse Res"},{"key":"10.1016\/j.jsxm.2020.12.001_bib44","series-title":"Qualitative inquiry and research design: choosing among five approaches","author":"Creswell","year":"2013"},{"key":"10.1016\/j.jsxm.2020.12.001_bib45","series-title":"Doing qualitative research: a practical handbook","author":"Silverman","year":"2010"},{"key":"10.1016\/j.jsxm.2020.12.001_bib46","series-title":"The Sage handbook of qualitative data collection","year":"2018"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609520310651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609520310651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T14:48:15Z","timestamp":1675954095000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/18\/2\/353\/6956010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1743609520310651"],"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2020.12.001","relation":{},"ISSN":["1743-6095"],"issn-type":[{"value":"1743-6095","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen Deprivation Therapy in Pedophilic Disorder: Exploring the Physical, Psychological, and Sexual Effects From a Patient's Perspective","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}